Phase 3 Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Shift Work Disorder (a sleep condition caused by working non-traditional hours) according to recognised international diagnostic standards.
- People who are willing and able to provide written consent before any study procedures begin.
- People aged between 18 and 65 years old (inclusive), of any gender.
Who may not be able to join:
- People who have previously taken solriamfetol (also known as Sunosi), whether through another clinical trial or a prescription.
- People who are unable to follow the procedures required by the study.
- People whom the study doctor considers medically unsuitable for participation.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 212-332-5061
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline to Week 12 in the mean sleep latency time as measured by the Maintenance of Wakefulness Test (MWT).; Change from Baseline to Week 12 in the Clinical Global Impressions of Severity of Illness (CGI-S) for sleepiness during the night shift.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.